Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset - Biora Therapeutics (NASDAQ:BIOR)
Monetization of legacy asset brings in $3 million in nondilutive capital Convertible notes exchange brings in another $2.8 million in new capital and reduces Biora's net debt SAN DIEGO, March 11, 2024 (GLOBE
United States Chuck Padala Biora Therapeutics Inc Enumera Molecular Inc Context Capital Enumera Molecular
Source: benzinga.com